Recombinant multi-species SUZ12 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SUZ12 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This zinc finger gene has been identified at the breakpoints of a recurrent chromosomal translocation reported in endometrial stromal sarcoma. Recombination of these breakpoints results in the fusion of this gene and JAZF1. The protein encoded by this gene contains a zinc finger domain in the C terminus of the coding region. [provided by RefSeq, Jul 2009]
The Alternative Names of target: 2610028O16Rik,CHET9,Chromatin precipitated E2F target 9 protein (ChET 9 protein),D11Ertd530e,IMMAS,JJAZ1,Joined to JAZF1 protein,Polycomb protein SUZ12,SUZ12,Suppressor of zeste 12 protein homolog,Suz12,mKIAA0160

Target products collectionGo to SUZ12 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP6905-Ag-1/ GM-Tg-hg-IP6905-Ag-2 Human SUZ12 protein Human
GM-Tg-rg-IP6905-Ag-1/ GM-Tg-rg-IP6905-Ag-2 Rat SUZ12 protein Rat
GM-Tg-mg-IP6905-Ag-1/ GM-Tg-mg-IP6905-Ag-2 Mouse SUZ12 protein Mouse
GM-Tg-cynog-IP6905-Ag-1/ GM-Tg-cynog-IP6905-Ag-2 Cynomolgus/Rhesus macaque SUZ12 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP6905-Ag-1/ GM-Tg-felg-IP6905-Ag-2 Feline SUZ12 protein Feline
GM-Tg-cang-IP6905-Ag-1/ GM-Tg-cang-IP6905-Ag-2 Canine SUZ12 protein Canine
GM-Tg-bovg-IP6905-Ag-1/ GM-Tg-bovg-IP6905-Ag-2 Bovine SUZ12 protein Bovine
GM-Tg-equg-IP6905-Ag-1/ GM-Tg-equg-IP6905-Ag-2 Equine SUZ12 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP6905-Ag-1/ GM-Tg-hg-IP6905-Ag-2; GM-Tg-rg-IP6905-Ag-1/ GM-Tg-rg-IP6905-Ag-2;
GM-Tg-mg-IP6905-Ag-1/ GM-Tg-mg-IP6905-Ag-2; GM-Tg-cynog-IP6905-Ag-1/ GM-Tg-cynog-IP6905-Ag-2;
GM-Tg-felg-IP6905-Ag-1/ GM-Tg-felg-IP6905-Ag-2; GM-Tg-cang-IP6905-Ag-1/ GM-Tg-cang-IP6905-Ag-2;
GM-Tg-bovg-IP6905-Ag-1/ GM-Tg-bovg-IP6905-Ag-2; GM-Tg-equg-IP6905-Ag-1/ GM-Tg-equg-IP6905-Ag-2
Products Name SUZ12 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SUZ12
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SUZ12 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.